Session 9: Practical Opioid Use Disorder Treatment for Providers

Egg Harbor, WI US
July 31, 2025 to August 1, 2025

Opioid Use Disorder continues to be a national epidemic with concerning prevalence and mortality. The evolution of illicit synthetic high-potency opiates, including fentanyl and its analogues, has greatly contributed to overall morbidity and mortality in people who use opioids.  Because high-potency opioids commonly contaminate supplies of other illicit drugs, opioid-naïve individuals are now experiencing the devastating consequences of these powerful drugs. In response to such concerns, efforts to improve access to first-line medications for opioid use disorder (MOUD), have intensified. In particular, the DATA waiver that previously placed barriers on buprenorphine prescribing has been eliminated, as of January 2023, thereby increasing the potential pool of prescribers to anyone who holds a DEA controlled substance registration. While this progress is encouraging, there are still large numbers of prescribers who still lack the education, practical knowledge, or confidence to begin prescribing these life-saving medications.

This talk will impact a broad audience of anyone working with people exposed to opioids. We will focus especially on effective psychotherapeutic modalities since this population has a high rate of co-occurring mental health conditions.  Particular attention will be paid to social (e.g. sober living or peer support) and harm reduction interventions (e.g. needle exchange or naloxone).  Finally, prescribers will learn practical lessons on how to integrate prescribing buprenorphine into their clinical practice and meet the DEA requirement for buprenorphine prescribing.

Psychology CE Credit Statement
The Medical College of Wisconsin is approved by the American Psychological Association to sponsor continuing education for psychologists. The Medical College of Wisconsin maintains responsibility for this program and its content.

This activity contains content or processes that may be potentially stressful.

Target Audience

  • Physicians
  • Nurse Practitioners
  • Physician Assistants
  • Nurses
  • Pharmacists
  • Psychologists
  • Social Workers
  • Psychiatry Residents
  • Medical Students
  • Allied Health Professionals

Learning Objectives

Participants who engage in this education intervention will be able to:
 
  • Utilize lessons from the history of opioid addiction in modern treatment & advocacy
  • Describe the current epidemiology and underlying neurobiology of opioid use disorder
  • Use screening, assessment, and diagnosis of opioid use disorder
  • Assess commonly co-occurring conditions (focusing on pain, addictive disorders, and psychiatric conditions)
  • Analyze medications for opioid use disorder (MOUD) like buprenorphine, methadone, and naltrexone with psychosocial treatments to optimize recovery outcomes
Additional information

Contact

Name: 
Caimen Masterson
Phone Number: 
+1 (414) 955-7250
Course summary
Available credit: 
  • 8.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 8.00 APA
    APA credit.
  • 8.00 Hours of Participation
    Hours of Participation credit.
  • 8.00 NASW
  • 8.00 NP Pharmacology
    NP Pharmacology credit.
  • 8.00 NP Contact Hours
  • 8.00 PA
    PA credit.
Course opens: 
01/10/2025
Course expires: 
07/30/2025
Event starts: 
07/31/2025 - 8:30am CDT
Event ends: 
08/01/2025 - 12:35pm CDT
Cost:
$402.00

Thursday:

  • Opioid addiction; past, present, and future
  • Opioid Use Disorder
    • Epidemiology
    • Neurobiology
    • Screening, assessment, and diagnosis
  • Co-occurring conditions
    • Co-occurring mental health conditions
    • Other substance use disorders
    • Pain

Friday:

  • MOUD (Medications for Opioid Use Disorder)
  • Psychosocial treatments for OUD
    • Psychotherapeutic approaches
    • Harm Reduction in OUD
    • Matching Care Intensity to Patient Needs
    • Other treatment strategies
The Landmark Resort
4929 Landmark Drive
Egg Harbor, WI 54209
United States
+1 (800) 273-7877

Lodging in July and August is in great demand; you must make reservations early. A block of suites has been set aside at the Landmark Resort. These suites will be held until June 6th, 2025, or until they are filled.

From its site on the bluff, the Landmark offers outstanding views of the waters of Green Bay with 294 units comprised of 1, 2, and 3-bedroom suites. Facilities include the Carrington Pub and Grill, 1 indoor and 3 outdoor pools, 2 tennis courts, whirlpools, steam rooms, and a fitness center and game room. The Landmark Resort is Door County’s largest and best full-service facility.

The Landmark Resort
4929 Landmark Drive
Egg Harbor, Wisconsin 54209

Reservations: (800) 273-7877
http://www.thelandmarkresort.com
To book through our discounted group rate, please call the Landmark reservation line at (800) 273-7877 and state that you are attending the Door County Summer Institute. No group code is required.
Group rates cannot be booked online.

Stephen Brandt, MD, is an Assistant Professor of Psychiatry and Addiction Psychiatrist with the Medical College of Wisconsin, joining the faculty in August 2023. He completed both his general psychiatry residency and addiction psychiatry fellowship at Indiana University in Indianapolis, IN. Most of his clinical time is spent practicing outpatient addiction psychiatry at MCW Tosa Psychiatry Center.  He also collaborates with the Froedtert Menomonee Falls Hospital Substance Use Intensive Outpatient Program (IOP) and the Froedtert Hospital Psychiatry Consult Liaison team.

Matthew E. Stohs, MD, received his B.S. in Biology from Valparaiso University and M.D. from Tulane University in New Orleans, Louisiana.  He completed his psychiatry residency and addiction psychiatry fellowship at Mayo Clinic in Rochester, MN.  He is board-certified in addiction psychiatry, addiction medicine, and general psychiatry.  He is the addiction psychiatry fellowship director at the Medical College of Wisconsin (MCW).   As medical director for the outpatient addiction clinic at Milwaukee VA Medical Center, he treats veterans with co-occurring mental health and addictive disorders. He is the Milwaukee lead site investigator (LSI) for the VA Cooperative Studies Program (CSP) clinical trial comparing the effectiveness of sublingual vs. monthly injectable buprenorphine for the treatment of opioid use disorder (VA-BRAVE).

Activity Director:
Carlyle H Chan, MD
Professor of Psychiatry and 
the Institute for Health and Equity-Bioethics and Humanities
Medical College of Wisconsin

Planning Committee Members:
Ellen Leitner, MSW, LCSW
Department of Psychiatry and Behavioral Medicine
Medical College of Wisconsin

Kevin Bozymski, PharmD, BCPS, BCPP
Assistant Professor, Department of Clinical Science
Medical College of Wisconsin School of Pharmacy 
Assistant Professor, Department of Psychiatry and Behavioral Medicine
Medical College of Wisconsin

Kylie Lenz, PA-C
Physician Assistant 
Department of Psychiatry and Behavioral Medicine
Medical College of Wisconsin

Heather M. Smith, PhD, ABPP
Lead Psychologist
Director of Psychology Training
Milwaukee VA Medical Center
Associate Professor
Department of Psychiatry and Behavioral Medicine
Medical College of Wisconsin

Marisa Stich, APNP
Department of Psychiatry and Behavioral Medicine
Medical College of Wisconsin

In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

  • Carlyle H Chan
  • Ellen Leitner
  • Kevin Bozymski
  • Kylie Lenz
  • Heather M. Smith
  • Marisa Stich
  • Stephen Brandt
  • Matthew E. Stohs

Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit Statement
The Medical College of Wisconsin designates this live activity for a maximum of 8 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 8  hours of participation for continuing education for allied health professionals.

National Association of Social Workers Credit Statement
This program is Approved by the National Association of Social Workers (Approval # 886840778-6225) for 8 continuing education contact hours.

American Association of Nurse Practitioners Credit Statement
The Medical College of Wisconsin, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 150930. This program has been approved for 8 contact hours of continuing education (which includes 8 hours of pharmacology). 

American Academy of Physician Assistants Credit Statement
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 8 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Available Credit

  • 8.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 8.00 APA
    APA credit.
  • 8.00 Hours of Participation
    Hours of Participation credit.
  • 8.00 NASW
  • 8.00 NP Pharmacology
    NP Pharmacology credit.
  • 8.00 NP Contact Hours
  • 8.00 PA
    PA credit.

Price

Cost:
$402.00
Please login or register to take this course.

*All registrations will be assessed $27.00 non-refundable processing fee, per session.


Credit MUST be claimed before November 30, 2025.
We highly encourage you to complete the evaluation and credit steps before leaving on your last day!
 

Early Bird! Tuition for 5-day sessions will be reduced to $695 and $375 for 2-day sessions, if received by June 1, 2025Tuition for 5-day sessions (3 hrs/day) is $745.  Tuition for 2-day sessions (4 hrs/day) is $395. Graduate and medical students and resident physicians will have a discounted rate, so please contact Caimen at [email protected] to inquire about this discount.

To receive a refund, the request must be made 15 days before the requested session begins. If the refund request is received less than 15 days before the session begins, the registration fee will be forfeited. There is also a $50 cancellation fee, should the request be received within the allotted window. Each session is also charged a non-refundable $27 processing fee.   
 

2-Day Sessions

EARLY BIRD PRICING

PRICING AFTER JUNE 1st

$375

$395


PLEASE NOTE! The billing address entered upon checkout must match the billing address on the credit card you will be using to pay for this course. MCW accepts MasterCard, VISA and Discover card. For a more user-friendly registration and payment experience, Google Chrome and Mozilla Firefox are the recommended web browsers.

Registration scams:
Registration for courses managed by MCW Office of Continuing Professional Development can only be completed through our portal at https://ocpe.mcw.edu/. Course registrations made through other sites cannot be honored. MCW Office of Continuing Professional Development is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com. Please report any unauthorized websites or solicitations for registrations to [email protected].